Literature DB >> 2544051

Myoepithelioma--new concepts of histology and classification: a light and electron microscopic study.

I Dardick1, M J Thomas, A W van Nostrand.   

Abstract

Based on histological, immunohistochemical, and ultrastructural studies, it is now apparent that the modified myoepithelial cell component of pleomorphic adenomas has a considerable range of cytological features. We reasoned that myoepitheliomas could be tumors with a similar spectrum of neoplastic myoepithelium but lacking the ductal element displayed in pleomorphic adenomas. A review of available salivary gland tumors identified 40 examples based on this definition. Architecturally, these myoepitheliomas displayed either nonmyxoid (solid), myxoid (pleomorphic adenoma-like), reticular (canalicularlike), or mixed growth patterns, while cytologically the lesions were composed of spindle-type (32.5%), hyaline-type (7.5%), epithelial-type (45.0%), clear-type (2.5%), or mixed-type (12.5%) tumor cells. Electron microscopy was carried out on eight examples and detailed immunohistochemistry on two methanol-fixed cases. As a result of the current review of myoepitheliomas and the description of similar lesions in the literature, it is our contention that salivary gland myoepitheliomas are not as rare as has been purported.

Entities:  

Mesh:

Year:  1989        PMID: 2544051     DOI: 10.3109/01913128909057442

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  27 in total

1.  Immunohistochemical and ultrastructural correlates of muscle-actin expression in pleomorphic adenomas and myoepitheliomas based on comparison of formalin and methanol fixation.

Authors:  I Dardick; V L Ostrynski; J K Ekem; R Leung; A P Burford-Mason
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  S-100 protein antibodies do not label normal salivary gland myoepithelium. Histogenetic implications for salivary gland tumors.

Authors:  I Dardick; M Stratis; W R Parks; F G DeNardi; H J Kahn
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

3.  Secretory myoepithelial carcinoma: a histologic and molecular survey and a proposed nomenclature for mucin producing signet ring tumors.

Authors:  Jassem M Bastaki; Bibianna M Purgina; Sanja Dacic; Raja R Seethala
Journal:  Head Neck Pathol       Date:  2014-01-21

4.  Salivary gland myoepithelioma variants. Histological, ultrastructural, and immunocytological features.

Authors:  I Dardick; S Cavell; M Boivin; D Hoppe; W R Parks; J Stinson; S Yamada; B F Burns
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  Comparative histogenesis and morphogenesis of mucoepidermoid carcinoma and pleomorphic adenoma. An ultrastructural study.

Authors:  I Dardick; M R Gliniecki; J G Heathcote; A Burford-Mason
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

6.  Clear cell myoepithelial carcinoma in the base of the tongue: Case report and review of the literature.

Authors:  Jun Hee Park; Ji Yun Choi; Ran Hong; Nam Yong DO
Journal:  Oncol Lett       Date:  2012-09-07       Impact factor: 2.967

7.  Myoepithelioma of a minor salivary gland of the cheek: case report.

Authors:  E Ferri; I Pavon; E Armato; S Cavaleri; P Capuzzo; F Ianniello
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-02       Impact factor: 2.124

8.  Unusual biliary myoepithelial carcinoma in liver-case report and immunohistochemical study.

Authors:  Wael Hassan; Junko Nishi; Shinjiro Tomiyasu; Tadahito Urakado; Katsuki Haraoka; Tuyoshi Yamanaka; Shigetoshi Fujiyama; Takaaki Ito
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 9.  Benign myoepithelioma of the lacrimal gland: report of a case.

Authors:  Andrea Bolzoni; Luca Pianta; Davide Farina; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-05-11       Impact factor: 2.503

10.  Myoepithelioma of the lacrimal gland: report of a case with spindle cell morphology.

Authors:  R L Font; A Garner
Journal:  Br J Ophthalmol       Date:  1992-10       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.